Human medicines European public assessment report (EPAR): Amvuttra, vutrisiran, Date of authorisation: 15/09/2022, Revision: 6, Status: Authorised

Expert panel support for orphan medical devices

Orphan medical devices regular process: 2027 timetable

Scientific advice for high-risk medical devices

Human medicines European public assessment report (EPAR): Perjeta, pertuzumab, Date of authorisation: 04/03/2013, Revision: 27, Status: Authorised

Advice to medical device manufacturers - 2027 Timetable

Human medicines European public assessment report (EPAR): Zilbrysq, zilucoplan, Date of authorisation: 01/12/2023, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Zercepac, trastuzumab, Date of authorisation: 27/07/2020, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Colchicine Agepha Pharma, colchicine, Date of authorisation: 24/07/2026, Status: Authorised

EMA Biotech Hub and Technology Transfer Offices (TTOs) engagement workshop , Online, European Medicines Agency, Amsterdam, the Netherlands, from 16 September 2026, 09:30 (CEST) to 16 September 2026, 16:30 (CEST)